LINC-23. Factors influencing outcomes of older children with Medulloblastoma over 15 years in Peru, a resource limited setting
Rosdali Díaz-Coronado(Instituto Nacional de Enfermedades Neoplásicas), Diana S. Osorio(Nationwide Children's Hospital), Sharon L. Chávez-Paredes(Instituto Nacional de Enfermedades Neoplásicas), Joseph Stanek(Nationwide Children's Hospital), William Quispe-Valverde(Instituto Nacional de Enfermedades Neoplásicas), James B. Reinecke(Michigan United), Yesenia Miranda-Tunque(Instituto Nacional de Enfermedades Neoplásicas), Raymundo Sernaque-Quintana(Instituto Nacional de Enfermedades Neoplásicas), Luis Ojeda-Medina(Instituto Nacional de Enfermedades Neoplásicas), Eddy Hernández-Broncano(Instituto Nacional de Enfermedades Neoplásicas), Sandro Casavilca‐Zambrano(Institute for Anthropological Research), Ebert Torres-Malca(Instituto Nacional de Enfermedades Neoplásicas), Jonathan L. Finlay(The Ohio State University), Adela Heredia-Zelaya(Instituto Nacional de Enfermedades Neoplásicas), Juan L Garcia-Leon(Instituto Nacional de Enfermedades Neoplásicas), Enrique Orrego-Puelles(Instituto Nacional de Enfermedades Neoplásicas), Pamela García-Corrochano(Instituto Nacional de Enfermedades Neoplásicas)
Cited by 0
Related Papers
Alterations in ALK/ROS1/NTRK/MET drive a group of infantile hemispheric gliomas
|Nature Communications|2019|372
COVID-19 in immunocompromised patients: A systematic review of cancer, hematopoietic cell and solid organ transplant patients
|Journal of Infection|2021|248
Pilot study of high-dose thiotepa and etoposide with autologous bone marrow rescue in children and young adults with recurrent CNS tumors. The Children's Cancer Group.
|Journal of Clinical Oncology|1996|203
High-dose carboplatin, thiotepa, and etoposide with autologous stem-cell rescue for patients with recurrent medulloblastoma. Children's Cancer Group.
|Journal of Clinical Oncology|1998|188